A double-blind, randomized, cross-over, placebo-controlled to evaluate the antihistamine effects of olopatadine and levocetirizine during a 24-h period in healthy volunteers.
Phase of Trial: Phase I
Latest Information Update: 18 Sep 2015
At a glance
- Drugs Levocetirizine (Primary) ; Olopatadine (Primary)
- Indications Urticaria
- Focus Therapeutic Use
- 18 Sep 2015 New trial record